Robotic-assisted Versus Conventional Laparoscopic Surgery in Obese Patients With Early Endometrial Cancer

Data across literature suggest that robotic surgery may offer benefit specifically in patient with morbid obesity with endometrial cancer, but to date no randomized trials have been conducted to confirm these observations. This randomized controlled multicentric trial aims to evaluate the most appropriate minimally invasive surgical approach in morbidly obese (BMI \>= 30) patients with endometrial carcinoma.

Trial Details

NCT ID
NCT05974995
Phase
NA
Sponsor
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Status
RECRUITING
Cancer Type
Uterine Cancer
Interventions
  • Robot-assisted surgery
  • Laparoscopic surgery
Locations (sample)
  • Rome, Italy|41.89193,12.51133

Key Eligibility Criteria

  • Histologically confirmed endometrioid endometrial cancer
  • Clinical early stage (stage I)
  • No contraindication for minimally invasive surgery
  • Written informed consent.

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Uterine Cancer Trials on Trialify →